New range of influenza antigens for vaccine development
The Native Antigen Company (part of LGC Clinical Diagnostics) has launched its latest range of influenza antigens for the southern hemisphere’s 2023 flu season. The latest influenza antigens will help support development of vaccines and diagnostics as part of the ongoing vaccine reformulation programme, helping to ensure… Read More